Global Small Cell Lung Cancer Therapeutics Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 105

Report ID: 3642

Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell carcinoma. It can be further classified into two stages: limited-stage small cell lung cancer and extensive-stage small cell lung cancer. Small cell lung cancer is caused by smoking tobacco, or second hand smoking, or on exposure to asbestos, chromium, arsenic, nickel, soot, or radon. The common symptoms associated with lung cancer are chest pain, incurable cough, blood in sputum, fatigue, loss of appetite, unintentional weight loss, shortness of breath, and wheezing. Small cell lung cancer has a poor prognosis and gets diagnosed only at the late stage of disease progression, and hence, has a high mortality rate. There are no therapies available to cure small cell lung cancer in the market.
In 2018, the global Small Cell Lung Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Small Cell Lung Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Small Cell Lung Cancer Therapeutics development in United States, Europe and China.

The key players covered in this study
Sanofi
Bristol-Myers Squibb
GlaxoSmithKline
Menarini
Ziopharm Oncology
Merck
Novartis
AstraZeneca
Takeda Pharmaceutical
Teva Pharmaceutical
Eli Lilly
Mylan
Sun Pharmaceuticals Industries
Amgen
Ono Pharmaceutical
Shanghai Jinhe Bio-Technology

Market segment by Type, the product can be split into
Biologics
Small molecules

Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Small Cell Lung Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Small Cell Lung Cancer Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Small Cell Lung Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Biologics
1.4.3 Small molecules
1.5 Market by Application
1.5.1 Global Small Cell Lung Cancer Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Small Cell Lung Cancer Therapeutics Market Size
2.2 Small Cell Lung Cancer Therapeutics Growth Trends by Regions
2.2.1 Small Cell Lung Cancer Therapeutics Market Size by Regions (2014-2025)
2.2.2 Small Cell Lung Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Small Cell Lung Cancer Therapeutics Market Size by Manufacturers
3.1.1 Global Small Cell Lung Cancer Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Small Cell Lung Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Small Cell Lung Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Small Cell Lung Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Small Cell Lung Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Small Cell Lung Cancer Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
5.2 Small Cell Lung Cancer Therapeutics Key Players in United States
5.3 United States Small Cell Lung Cancer Therapeutics Market Size by Type
5.4 United States Small Cell Lung Cancer Therapeutics Market Size by Application

6 Europe
6.1 Europe Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
6.2 Small Cell Lung Cancer Therapeutics Key Players in Europe
6.3 Europe Small Cell Lung Cancer Therapeutics Market Size by Type
6.4 Europe Small Cell Lung Cancer Therapeutics Market Size by Application

7 China
7.1 China Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
7.2 Small Cell Lung Cancer Therapeutics Key Players in China
7.3 China Small Cell Lung Cancer Therapeutics Market Size by Type
7.4 China Small Cell Lung Cancer Therapeutics Market Size by Application

8 Japan
8.1 Japan Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
8.2 Small Cell Lung Cancer Therapeutics Key Players in Japan
8.3 Japan Small Cell Lung Cancer Therapeutics Market Size by Type
8.4 Japan Small Cell Lung Cancer Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
9.2 Small Cell Lung Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Small Cell Lung Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Small Cell Lung Cancer Therapeutics Market Size by Application

10 India
10.1 India Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
10.2 Small Cell Lung Cancer Therapeutics Key Players in India
10.3 India Small Cell Lung Cancer Therapeutics Market Size by Type
10.4 India Small Cell Lung Cancer Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Small Cell Lung Cancer Therapeutics Market Size (2014-2019)
11.2 Small Cell Lung Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Small Cell Lung Cancer Therapeutics Market Size by Type
11.4 Central & South America Small Cell Lung Cancer Therapeutics Market Size by Application

12 International Players Profiles
12.1 Sanofi
12.1.1 Sanofi Company Details
12.1.2 Company Description and Business Overview
12.1.3 Small Cell Lung Cancer Therapeutics Introduction
12.1.4 Sanofi Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.1.5 Sanofi Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 Small Cell Lung Cancer Therapeutics Introduction
12.2.4 Bristol-Myers Squibb Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.2.5 Bristol-Myers Squibb Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Small Cell Lung Cancer Therapeutics Introduction
12.3.4 GlaxoSmithKline Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Menarini
12.4.1 Menarini Company Details
12.4.2 Company Description and Business Overview
12.4.3 Small Cell Lung Cancer Therapeutics Introduction
12.4.4 Menarini Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.4.5 Menarini Recent Development
12.5 Ziopharm Oncology
12.5.1 Ziopharm Oncology Company Details
12.5.2 Company Description and Business Overview
12.5.3 Small Cell Lung Cancer Therapeutics Introduction
12.5.4 Ziopharm Oncology Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.5.5 Ziopharm Oncology Recent Development
12.6 Merck
12.6.1 Merck Company Details
12.6.2 Company Description and Business Overview
12.6.3 Small Cell Lung Cancer Therapeutics Introduction
12.6.4 Merck Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.6.5 Merck Recent Development
12.7 Novartis
12.7.1 Novartis Company Details
12.7.2 Company Description and Business Overview
12.7.3 Small Cell Lung Cancer Therapeutics Introduction
12.7.4 Novartis Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.7.5 Novartis Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Small Cell Lung Cancer Therapeutics Introduction
12.8.4 AstraZeneca Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.8.5 AstraZeneca Recent Development
12.9 Takeda Pharmaceutical
12.9.1 Takeda Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Small Cell Lung Cancer Therapeutics Introduction
12.9.4 Takeda Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.9.5 Takeda Pharmaceutical Recent Development
12.10 Teva Pharmaceutical
12.10.1 Teva Pharmaceutical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Small Cell Lung Cancer Therapeutics Introduction
12.10.4 Teva Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2014-2019)
12.10.5 Teva Pharmaceutical Recent Development
12.11 Eli Lilly
12.12 Mylan
12.13 Sun Pharmaceuticals Industries
12.14 Amgen
12.15 Ono Pharmaceutical
12.16 Shanghai Jinhe Bio-Technology

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details